SCHEMBL7015906

SCHEMBL7015906

CCCc1cc(Cl)nc(SCC)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
KMT2A Q03164 3/20 0.38
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
HPGD P15428 3/20 0.37
MAPT P10636 4/20 0.36
KDM5B Q9UGL1 1/20 0.36
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSP90AA1 P07900 1/20 0.34
BACE1 P56817 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4447774 0.84 HTT (0.45) CYP1A2KMT2AKDM4ENOS3NOS1
SCHEMBL22142948 0.82 KDM4E (0.44) CYP1A2KMT2AMAPK1KDM4EHPGD
SCHEMBL11834300 0.82 CTSK (0.40) CYP1A2KMT2AKDM4EHPGDCTSS
SCHEMBL10846214 0.80 KMT2A (0.53) CYP1A2KMT2AMAPK1HPGDMEN1
SCHEMBL11272018 0.76 LMNA (0.52) CYP1A2KMT2AMAPK1KDM4EMAPT
SCHEMBL5672114 0.75 NOS3 (0.42) CYP1A2KMT2AKDM4ENOS3NOS1
SCHEMBL3802657 0.73 ALDH1A1 (0.46) CYP1A2KDM4ENOS3NOS1NOS2
SCHEMBL5745860 0.72 HSP90AB1 (0.53) KMT2AKDM4ENOS3NOS1NOS2
SCHEMBL3451654 0.71 KDM4E (0.57) KMT2AMAPK1KDM4EHPGDMAPT
SCHEMBL17209317 0.71 KMT2A (0.55) KMT2AKDM4EHPGDPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed